These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27699176)

  • 1. Effects of Bufei Yishen Granules Combined with Acupoint Sticking Therapy on Pulmonary Surfactant Proteins in Chronic Obstructive Pulmonary Disease Rats.
    Tian Y; Li J; Li Y; Dong Y; Yao F; Mao J; Li L; Wang L; Luo S; Wang M
    Biomed Res Int; 2016; 2016():8786235. PubMed ID: 27699176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bufei Yishen granules combined with acupoint sticking therapy suppress oxidative stress in chronic obstructive pulmonary disease rats: Via regulating peroxisome proliferator-activated receptor-gamma signaling.
    Li Y; Tian YG; Li JS; Dong YQ; Wang MH; Feng SX; Li LL; Mao J; Wang LL; Luo S
    J Ethnopharmacol; 2016 Dec; 193():354-361. PubMed ID: 27562320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufei Yishen granule combined with acupoint sticking improves pulmonary function and morphormetry in chronic obstructive pulmonary disease rats.
    Tian Y; Li Y; Li J; Xie Y; Wang M; Dong Y; Li L; Mao J; Wang L; Luo S
    BMC Complement Altern Med; 2015 Aug; 15():266. PubMed ID: 26253241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bufei Yishen Granules Combined with Acupoint Sticking Therapy Suppress Inflammation in Chronic Obstructive Pulmonary Disease Rats: Via JNK/p38 Signaling Pathway.
    Tian Y; Li Y; Li J; Feng S; Li S; Mao J; Xie Y; Liu X; Dong H; Zheng W; Wang M
    Evid Based Complement Alternat Med; 2017; 2017():1768243. PubMed ID: 29234369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bufei Yishen Granule combined with acupoint-sticking therapy in patients with stable chronic obstructive pulmonary disease: study protocol of a multicenter, randomized, double-blind, active-controlled trial.
    Li JS; Li SY; Yu XQ; Xie Y
    Zhong Xi Yi Jie He Xue Bao; 2011 Dec; 9(12):1312-8. PubMed ID: 22152769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease.
    Li Y; Li JS; Li WW; Li SY; Tian YG; Lu XF; Jiang SL; Wang Y
    BMC Complement Altern Med; 2014 Apr; 14():140. PubMed ID: 24766819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease.
    Li JS; Li Y; Li SY; Wang YY; Deng L; Tian YG; Jiang SL; Wang Y
    Zhong Xi Yi Jie He Xue Bao; 2012 Sep; 10(9):1039-48. PubMed ID: 22979936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Bufei Yishen Granules Combined with Electroacupuncture in Rats with Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-
    Ma J; Tian Y; Li J; Zhang L; Wu M; Zhu L; Liu S
    Evid Based Complement Alternat Med; 2019; 2019():6708645. PubMed ID: 31275415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.
    Li J; Ma J; Tian Y; Zhao P; Liu X; Dong H; Zheng W; Feng S; Zhang L; Wu M; Zhu L; Liu S; Zhao D
    J Ethnopharmacol; 2020 Jul; 257():112796. PubMed ID: 32344236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Bufei Yishen Granule combined with acupoint sticking therapy on quality of life in patients with stable chronic obstructive pulmonary disease.
    Xie Y; Li JS; Yu XQ; Li SY; Zhang NZ; Li ZG; Shao SJ; Guo LX; Zhu L; Zhang YJ
    Chin J Integr Med; 2013 Apr; 19(4):260-8. PubMed ID: 23546629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease.
    Dong Y; Li Y; Sun Y; Mao J; Yao F; Tian Y; Wang L; Li L; Li S; Li J
    BMC Complement Altern Med; 2015 Mar; 15():51. PubMed ID: 25888379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula.
    Zhao P; Li J; Tian Y; Mao J; Liu X; Feng S; Li J; Bian Q; Ji H; Zhang L
    J Ethnopharmacol; 2018 May; 217():152-162. PubMed ID: 29454913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
    Li JS; Li SY; Yu XQ; Xie Y; Wang MH; Li ZG; Zhang NZ; Shao SJ; Zhang YJ; Zhu L; Guo LX; Bai YP; Wang YF
    J Ethnopharmacol; 2012 Jun; 141(2):584-91. PubMed ID: 21911051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics study on model rats of chronic obstructive pulmonary disease treated with Bu‑Fei Jian‑Pi.
    Li J; Yang L; Li Y; Tian Y; Li S; Jiang S; Wang Y; Li X
    Mol Med Rep; 2015 Feb; 11(2):1324-33. PubMed ID: 25370181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence and long-term effects of three methods for regulating and invigorating fei-shen on T lymphocyte subsets and CD4+ CD25+ in COPD rats].
    Jiang SL; Li Y; Tian YG; Li JS; Li SY; Wang Y; Wang YY; Deng L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1538-44. PubMed ID: 24483117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-
    Jin F; Zhang L; Chen K; Miao Y; Liu Y; Tian Y; Li J
    Biomed Res Int; 2022; 2022():3360771. PubMed ID: 35586807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Compatibility characteristics of Bufei Yishen formula III in regulating chronic obstructive pulmonary disease mucus hypersecretion].
    Qin Y; Li M; Tian Y; Zhao P; Li K; Li C; Li J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1309-1314. PubMed ID: 34980299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism underlying the therapeutic effects of effective component compatibility of Bufei Yishen formula III combined with exercise rehabilitation on chronic obstructive pulmonary disease.
    Huang L; Guan Q; Lu R; Zhang Z; Liu C; Tian Y; Li J
    Ann Med; 2024 Dec; 56(1):2403729. PubMed ID: 39276358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling.
    Xu K; Ma J; Lu R; Shao X; Zhao Y; Cui L; Qiu Z; Tian Y; Li J
    Biosci Rep; 2023 Nov; 43(11):. PubMed ID: 36799253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.